Skip to main content

Global Lab-on-a-chip (LOC) Market Size to Reach USD 19.23 Billion in 2032 | Emergen Research

Lab-on-a-chip market revenue growth is being driven by increasing demand for point of care testing, rising prevalence of chronic diseases, and growing applications of genomics and proteomics in cancer research

Vancouver, Oct. 26, 2023 (GLOBE NEWSWIRE) — The global Lab-on-a-chip (LOC) market size is expected to reach USD 19.23 Billion at a steady CAGR of 10.6% in 2032, according to latest analysis by Emergen Research. Increasing prevalence of cancer is a major factor driving lab-on-a-chip market revenue growth to a significant extent, and this trend is expected to continue going ahead. LOC devices are used in detection of pathogens, and also for biomarker-based identification and early diagnosis of oral cancer. High incidence of swine flu, malaria, Ebola virus, and Zika virus are also fueling market revenue growth.

Receive the FREE Sample Report of Lab-on-a-chip (LOC) Market Research Insights @ https://www.emergenresearch.com/request-sample/622

LOC devices are portable and provide benefits of re-configurability and automated sample handling. These devices also offer rapid on-time diagnosis and are used for point-of-care diagnosis. Some of the applications of lab-on-a-chip in the biomedical field include immunoassay LOC for bacteria detection, gene chip, DNA chip, real-time PCR detection chips, cellular analysis chip, and flow cytometer LOC (for HIV).

Lab-on-a-chip technology is being explored for other applications by various small to medium sized enterprises mainly in North America, Asia, and Europe. Adoption of lab-on-a-chip has been relatively low across various application areas. Poor reproducibility and inconsistency of results using lab-on-a-chip is hampering growth of the market to some extent. However, advancements in technology have led to development of advanced technologies and assays, which are capable of early and easy detection of pathogenicity and development in drug discovery, which will create rising demand for this technology in future. Rising prevalence of chronic diseases is also propelling revenue growth of the lab-on-a-chip market.

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/622

Scope of Research

Report DetailsOutcome
Market size in 2020USD 5.74 Billion
CAGR (2023–2032)10.6%
Revenue forecast in 2032USD 19.23 Billion
Base year for estimation2020
Historical data2017–2019
Forecast period2023–2032
Quantitative unitsRevenue in USD Billion and CAGR in % from 2023 to 2032.
Report coverageRevenue forecast, company ranking, competitive landscape, growth factors, and trends.
Segments coveredProduct type, technology, application, end-use, and region.
Regional scopeNorth America; Europe; Asia Pacific; Latin America; Middle East & Africa.
Country scopeU.S., Canada, Mexico, Germany, U.K., France, Spain,  BENELUX, Switzerland, Rest of Europe, China, India, Japan, South Korea, Rest of APAC, Brazil, Rest of LATAM, Saudi Arabia, UAE, Israel, Rest of MEA.
Key companies profiledBecton, Dickinson and Company, PerkinElmer, Inc., Bio-Rad Laboratories, Agilent Technologies, Inc., Thermo Fisher Scientific, Siemens Healthcare, Abaxis Inc., Roche Diagnostics, Abbott Laboratories, and Danaher Corporation.
Customization scope10 hours of free customization and expert consultation.

MAJOR COMPANIES and Competitive Landscape

The global Lab-on-a-chip market is consolidated, with a few small- and medium-sized players accounting for majority revenue share. Established companies are engaged in various research and development activities and initiatives to develop and deploy new and more efficient technologies and solutions in the lab-on-a-chip market. Some prominent players operating in the market are:

  • Becton, Dickinson, and Company
  • PerkinElmer, Inc.
  • Bio-Rad Laboratories
  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific
  • Siemens Healthcare
  • Abaxis Inc.
  • Roche Diagnostics
  • Abbott Laboratories
  • Danaher Corporation

Strategic Development

In June 2020, Sengenics launched multi-antigen COVID-19 biochip test, ImmuSAFE. It is a lab-based biochip test, which uses the company’s patented KREX protein folding technology. ImmuSAFE enables the identification of target epitopes, titres, and Ig class/sub-class (IgG, IgA, IgM; IgG1-4) of antibodies produced at various stages of COVID-19 infection, from disease development, initial exposure, and post-recovery to post-vaccination.

Direct Order Can Be Placed Through This Link [Exclusive Copy] @ https://www.emergenresearch.com/select-license/622

Some Key Highlights From the Report

  • In February 2021, researchers at the University of Bristol used 3D printing to speed up development of lab-on-chip diagnostic systems with cost-effective microfluidic channels. This development can put lab-on-a-chip prototyping within the reach of researchers or clinicians with limited resources, where diagnostics can have the greatest impact.
  • Microarray is a tool used in laboratories to detect the expression of thousands of genes at the same time. Advancements in technology has propelled adoption of microarrays, and this is resulting in increasing usage of biochips in cancer diagnosis and treatment, and in personalized medicine, which will drive revenue growth of the microarray segment.
  • Lab-on-a-chip offers a wide range of opportunities for RNA and DNA sequencing. It is used to integrate an array of DNA probes, which are able to sequence genomes at a thousand time faster rate. All the biomolecular operations done on lab-on-a-chip show great potential for virus and bacteria detection and hold enormous possibilities for immunoassays.
  • Lab-on-a-chip market in North America accounted for the largest revenue share in 2020, due to rapid adoption of advanced technologies, increasing research and development activities of lab-on-a-chip, and increased investments by pharmaceutical companies in drug discovery. Moreover, presence of leading firms providing lab-on-a-chip is another factor resulting in robust market growth in the region.

For More Details On this Report @ https://www.emergenresearch.com/industry-report/lab-on-a-chip-market

Emergen Research has segmented the global lab-on-a-chip (LOC) market on the basis of product type, technology, application, end-use, and region:

  • Product Type Outlook (Revenue, USD Billion; 2019–2032)
    • Software
    • Reagents & Consumables
    • Instruments
  • Technology Outlook (Revenue, USD Billion; 2019–2032)
    • Microarrays
    • Microfluidics
  • Application Outlook (Revenue, USD Billion; 2019–2032)
    • Proteomics
    • Genomics
    • Drug Discovery
    • Diagnostics
  • End-use Outlook (Revenue, USD Billion; 2019–2032)
    • Diagnostic Labs
    • Hospitals
    • Biotechnology & Pharmaceutical Companies
    • Academic & Research Institutes
  • Regional Outlook (Revenue, USD Billion; 2019–2032)
    • North America
      1. U.S.
      2. Canada
      3. Mexico
    • Europe
      1. Germany
      2. U.K.
      3. France
      4. Spain
      5. BENELUX
      6. Switzerland
      7. Rest of Europe
    • Asia Pacific
      1. China
      2. India
      3. Japan
      4. South Korea
      5. Rest of APAC
    • Latin America
      1. Brazil
      2. Rest of LATAM
    • Middle East & Africa
      1. Saudi Arabia
      2. UAE
      3. Israel
      4. Rest Of MEA

Curated Reports You Shouldn’t Miss: Dive In Now!

Horticulture Lighting Market By Lighting Type (Interlighting, Toplighting), By Lighting Technology (Light-Emitting Diode (LED), High-Intensity Discharge (HID), By Application (Indoor Farms, Vertical Farms, Greenhouses), and By Region Forecast to 2028

Smart Greenhouse Market By Type (Hydroponics, Non-hydroponics), By Component (LED Grow Lights, HVAC System, Sensors & Control System), By End-use (Research & Educational Institutes, Commercial Growers), and By Region Forecast to 2028

Gaming Console Market Size, Share, Trends, By Platform, By Modality, By Application, By End-use, and By Region Forecast to 2028

Wi-Fi 6 Devices Market By Component (Controller/Switch, Gateways/Routers, Access Points), By Usage Type (Public, Private), By Application (Education, Healthcare, Retail, Automotive & Transportation, Government, Sports & Leisure, Hospitality), and By Region Forecast to 2028

Ambient Lighting Market By Type (Suspended Lights, Recessed Lights, Strip Lights), By Offering (Software & Services, Hardware), By End-use (Residential, Healthcare, Industrial, Office Buildings, Automotive), and By Region Forecast to 2028

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: https://www.emergenresearch.com/

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Explore Our Japanese Version: Lab-on-a-chip (LOC) Market

Explore Our Blogs and Insights Section: https://www.emergenresearch.com/insights

Read our Press Release @ https://www.emergenresearch.com/press-release/global-lab-on-a-chip-market

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.